S&P 500 Consumer Staples Sector SEC Filings — August 04, 2026

Q2 2026 adjusted EPS of $1.84, up 98% YoY, and total segment operating profit up 75% YoY to $1.45B, driven by Ag Services & Oilseeds (+129%) and Nutrition (+51%)

Raised full-year 2026 adjusted EPS guidance to $5.15–$5.60 (from $4.15–$4.70), implying ~20% upside at the midpoint, citing constructive biofuels environment

Crushing subsegment operating profit increased by $330M YoY, with record meal exports from Brazil and the U.S., indicating strong global demand

Adjusted operating profit rose 6.2% YoY to $757M and adjusted EPS up 10.4% to $1.80, despite flat organic sales, showing cost discipline

Adjusted gross margin expanded 190 bps YoY to 38.8%, indicating strong pricing or cost savings

Organic sales were down ~0.1% YoY, and China diaper allegations caused ~50 bps sales hit in Q2, with continued near-term impact expected

Reported diluted EPS from continuing operations fell to $1.22 from $1.33 YoY, and net income dropped to $345M from $509M, due to a $60M loss from discontinued operations and higher taxes

EVP Bartlett Daniel J sold 3,710 shares at $113.10 (~$420K) under a 10b5-1 plan, but retains 626,298 shares, indicating a minor, planned disposal

CFO Bruce Kofi A had 971 shares withheld for taxes at $35.75 (~$34.7K), a routine transaction with no change in beneficial ownership intent

Chief Growth Officer Corsi Patricia exercised 966 RSUs and had 404 shares withheld for taxes, showing continued equity vesting but no outright sale

Chief R&D Officer Slavtcheff Craig exercised 5,279 shares and had 1,711 withheld for taxes, indicating ongoing equity compensation but no market sale

Director DePinto Joseph Michael was awarded 1,007 shares, a routine director compensation event with no market transaction

False allegations about diaper quality in China negatively impacted sales by ~50 bps in Q2 and are expected to continue, with organic sales growth now expected ~100 bps below category growth

Q2 2026 included a $60M loss from discontinued operations vs. $68M income in Q2 2025, a $128M swing that materially impacted net income

Reported effective tax rate spiked to 37.9% in Q2 2026 from 22.6% in Q2 2025, significantly reducing reported EPS

Marketing, research and general expenses increased 16.3% YoY to $1,004M, outpacing sales growth and pressuring margins

Refined Products & Other subsegment declined 3% YoY, and equity earnings from Wilmar fell 22% YoY, indicating softness in certain processing and JV operations

EVP sold $420K under a 10b5-1 plan; while routine, it signals a potential lack of near-term upside conviction at current levels

Organic sales were flat (down ~0.1%) in Q2, indicating limited volume growth despite category growth, which could persist

The 10-K filing carries a medium risk level, warranting review for potential litigation, regulatory, or supply chain risks that could affect the sector

Full-year 2026 EPS guidance raised to $5.15–$5.60, implying ~20% upside from prior midpoint; investors should consider accumulating ahead of Q3 earnings

Constructive biofuels environment and record meal exports from Brazil and the U.S. support continued crushing margin strength

Nutrition segment operating profit up 51% YoY, indicating successful restructuring and potential for further margin recovery

Adjusted gross margin up 190 bps YoY to 38.8% and adjusted operating profit up 6.2%, suggesting cost savings and pricing power that could drive EPS growth if China issue resolves

If the China diaper allegations are addressed, organic sales could rebound to category growth, providing upside to current guidance

The $60M loss from discontinued operations may be a one-time event; if resolved, net income could normalize, improving reported EPS

CFO retains 256,345 shares, indicating strong insider alignment; any future buying could signal undervaluation at $35.75

Director DePinto's award of 1,007 shares aligns with shareholder interests, though not a strong signal; watch for future insider buying

ADM and Kimberly-Clark both reported strong adjusted margin improvements (ADM segment profit +75% YoY, KMB adjusted gross margin +190 bps) despite flat-to-modest sales growth, indicating a focus on cost discipline and pricing

ADM benefited from the Barcarena terminal returning to full operations, while Kimberly-Clark faced a China-specific headwind, showing how regional events can create divergent performance

Most insider transactions were tax withholdings or RSU exercises (Kimberly-Clark, General Mills), with only one planned sale (Walmart), suggesting no broad insider concern

ADM raised guidance sharply, while Kimberly-Clark lowered organic sales expectations, indicating a split in sector outlook between agricultural/commodity-linked and consumer product companies

No major buybacks or dividend changes were disclosed in these filings, suggesting companies are prioritizing balance sheet strength and operational investment over aggressive shareholder returns

Q3 2026 earnings (expected late Oct) to see if crushing and Nutrition momentum continues; watch for any update on Wilmar equity earnings

Monitor China diaper situation and any PR/regulatory updates; Q3 earnings will reveal if organic sales recover or deteriorate further

Watch for resolution of discontinued operations and tax rate normalization, which could boost reported EPS

Watch for further insider sales from EVP Bartlett or other executives; a pattern of selling could signal caution

Review 10-K for any risk factors that could impact the sector, such as supply chain or regulatory issues

Monitor CFO Bruce's future transactions; any outright sales could indicate concern, while purchases would be bullish

Watch for Q3 earnings calls from ADM and Kimberly-Clark to gauge whether margin expansion is sustainable and if China headwinds persist